Dawnrays Pharmaceutical (Holdings) (HKSE:02348) General and Admin. Expense : HK$117 Mil (TTM As of Jun. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Dawnrays Pharmaceutical (Holdings) General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Dawnrays Pharmaceutical (Holdings)'s General and Admin. Expense for the six months ended in Jun. 2024 was HK$58 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Jun. 2024 was HK$117 Mil.

Dawnrays Pharmaceutical (Holdings) General and Admin. Expense Historical Data

The historical data trend for Dawnrays Pharmaceutical (Holdings)'s General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dawnrays Pharmaceutical (Holdings) General and Admin. Expense Chart

Dawnrays Pharmaceutical (Holdings) Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

General and Admin. Expense

Get a 7-Day Free Trial

108.03

129.48

143.76

136.30

123.82

Dawnrays Pharmaceutical (Holdings) Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
General and Admin. Expense	Get a 7-Day Free Trial															63.53	75.78	64.73	59.09	58.29

Dawnrays Pharmaceutical (Holdings) General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$117 Mil.

Dawnrays Pharmaceutical (Holdings) General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of Dawnrays Pharmaceutical (Holdings)'s General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Dawnrays Pharmaceutical (Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dawnrays Pharmaceutical (Holdings) Ltd (HKSE:02348) » Definitions » General and Admin. Expense

Traded in Other Exchanges

N/A

Address

338 Hennessy Road, Units 3001-02, 30th Floor, CNT Tower, Wanchai, North Sea Centre, Hong Kong, HKG

Website

https://www.dawnrays.com

Dawnrays Pharmaceutical (Holdings) Ltd is a drug manufacturing company. The company operates two segments, including Intermediates and Bulk Medicines, and Finished Drugs. The revenue is derived from the Finished Drugs segment. Nearly all of the company's sales are generated in Mainland China. It utilizes strategic partnerships as a component of its international strategies. The company is open to exploring potential acquisitions as a component of its overall growth plan.

Executives

Li Kei Ling
Hung Yung Lai
Fortune United Group Limited	2101 Beneficial owner
Hunwick International Limited	2201 Interest of corporation controlled by you
Keysmart Enterprises Limited	2201 Interest of corporation controlled by you
Iu Pun	2202 Interest of your spouse
Toyo International Investment Limited
Leung Hong Man
Leung Yiu Sing
Chu Shuet Fong
Lo Mei Sai
Time Lead Investments Limited
Li Tung Ming
Fmr Llc	2201 Interest of corporation controlled by you

Dawnrays Pharmaceutical (Holdings) Headlines

No Headlines